Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome-Reference-Cited by-同舟云学术

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

Published:2015-09-04 Issue:31 Volume:6 Page:30859-30875
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rea Katia¹,Pinciroli Patrizia²,Sensi Marialuisa²,Alciato Federica³,Bisaro Brigitte⁴,Lozneanu Ludmila⁵,Raspagliesi Francesco⁶,Centritto Floriana²,Cabodi Sara⁴,Defilippi Paola⁴,Avanzi Gian Carlo³,Canevari Silvana²,Tomassetti Antonella¹

Affiliation:

1. Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Functional Genomics and Bioinformatics Core Facility, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

3. Department of Traslational Medicine, Università degli Studi del Piemonte Orientale, Novara, Italy

4. Department of Molecular Biotechnology and Health Sciences, University of Torino, Italy

5. Department of Morphofunctional Sciences, Histology, Morphopatology, “Grigore T. Popa” University of Medicine and Pharmacy, Iassy, Romania

6. Gynecology Oncology Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAM receptors in phagocytosis: Beyond the mere internalization of particles;Immunological Reviews;2023-08-19

2. Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial;Journal of Experimental & Clinical Cancer Research;2023-04-11

3. Axl and Vascular Endothelial Growth Factor Receptors Exhibit Variations in Membrane Localization and Heterogeneity Across Monolayer and Spheroid High-Grade Serous Ovarian Cancer Models;GEN Biotechnology;2023-02-01

4. Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway;Cells;2022-06-30

5. Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition;Frontiers in Immunology;2022-04-27